Home » Topics » BioWorld Science

BioWorld Science
RSS

RBT-9 shown effective against BK virus infection

Nov. 8, 2021

Novel UOX-iKO mouse as model of hyperuricemia

Nov. 8, 2021

Viking Therapeutics' dual GLP-1/GIP receptor agonists show potential in model of obesity

Nov. 8, 2021

Mineralocorticoid receptor antagonism ameliorates DKD phenotype in mice

Nov. 8, 2021

New JAK inhibitors patented by Gossamer Bio

Nov. 8, 2021

Aryl hydrocarbon receptor modulators discovered at Dong-A ST

Nov. 8, 2021

New GTPase KRAS mutant inhibitors discovered at Incyte

Nov. 8, 2021

Janssen identifies NLRP3 inflammasome inhibitors

Nov. 8, 2021

Roche describes new cyclic GMP-AMP synthase inhibitors

Nov. 8, 2021

Researchers develop a cystic fibrosis-related diabetes murine model

Nov. 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...